FR2132136A1 - - Google Patents

Info

Publication number
FR2132136A1
FR2132136A1 FR7210851A FR7210851A FR2132136A1 FR 2132136 A1 FR2132136 A1 FR 2132136A1 FR 7210851 A FR7210851 A FR 7210851A FR 7210851 A FR7210851 A FR 7210851A FR 2132136 A1 FR2132136 A1 FR 2132136A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7210851A
Other languages
French (fr)
Other versions
FR2132136B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of FR2132136A1 publication Critical patent/FR2132136A1/fr
Application granted granted Critical
Publication of FR2132136B1 publication Critical patent/FR2132136B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7210851A 1971-03-31 1972-03-28 Expired FR2132136B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUEE1907A HU162396B (en) 1971-03-31 1971-03-31

Publications (2)

Publication Number Publication Date
FR2132136A1 true FR2132136A1 (en) 1972-11-17
FR2132136B1 FR2132136B1 (en) 1975-04-25

Family

ID=10995361

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7210851A Expired FR2132136B1 (en) 1971-03-31 1972-03-28

Country Status (20)

Country Link
JP (1) JPS5144957B1 (en)
AT (1) AT316549B (en)
AU (1) AU464287B2 (en)
BE (1) BE781494A (en)
CA (1) CA1024147A (en)
CH (1) CH574438A5 (en)
CS (1) CS166043B2 (en)
DK (1) DK143500C (en)
ES (1) ES401342A1 (en)
FI (1) FI54709C (en)
FR (1) FR2132136B1 (en)
GB (1) GB1378964A (en)
HU (1) HU162396B (en)
IL (1) IL39058A (en)
NL (1) NL164853C (en)
PL (1) PL94559B1 (en)
SE (1) SE396219B (en)
SU (1) SU512712A3 (en)
YU (1) YU35015B (en)
ZA (1) ZA721972B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0209932A (en) 2001-05-22 2004-10-13 Neurogen Corp Pharmaceutically acceptable compound or salt thereof, pharmaceutical composition, packaged pharmaceutical preparation, methods for modulating mch binding to an mch receptor and mvc, to alter the signal transduction activity of an mch receptor in a cell, to treat a disease or disorder associated with pathogenic obesity mch receptor activation and to determine the presence or absence of mch receptor in a sample, and use of a compound
US7253168B2 (en) 2004-04-07 2007-08-07 Neurogen Corporation Substituted 1-benzyl-4-substituted piperazine analogues
BRPI0711873A2 (en) * 2006-05-30 2011-12-06 Janssen Pharmaceutica Nv substituted pyridyl amide compounds as h3 histamine receptor modulators, pharmaceutical composition, methods of manufacturing said compounds and use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Also Published As

Publication number Publication date
YU84872A (en) 1979-12-31
PL94559B1 (en) 1977-08-31
FI54709C (en) 1979-02-12
DK143500C (en) 1982-01-18
SE396219B (en) 1977-09-12
AT316549B (en) 1974-07-10
IL39058A (en) 1975-07-28
CA1024147A (en) 1978-01-10
AU464287B2 (en) 1975-08-05
ZA721972B (en) 1973-01-31
FI54709B (en) 1978-10-31
DE2215545A1 (en) 1972-10-12
IL39058A0 (en) 1972-05-30
FR2132136B1 (en) 1975-04-25
CS166043B2 (en) 1976-01-29
ES401342A1 (en) 1975-02-16
SU512712A3 (en) 1976-04-30
YU35015B (en) 1980-06-30
DE2215545B2 (en) 1975-07-31
NL164853C (en) 1981-02-16
NL7204296A (en) 1972-10-03
GB1378964A (en) 1975-01-02
NL164853B (en) 1980-09-15
BE781494A (en) 1972-07-17
DK143500B (en) 1981-08-31
HU162396B (en) 1973-02-28
CH574438A5 (en) 1976-04-15
JPS5144957B1 (en) 1976-12-01
AU4051572A (en) 1974-03-07

Similar Documents

Publication Publication Date Title
FR2132136B1 (en)
AU2691671A (en)
AU2941471A (en)
AU2684071A (en)
AU2742671A (en)
AU2894671A (en)
AU2952271A (en)
AU3005371A (en)
AU2880771A (en)
AU2486471A (en)
AU2684171A (en)
AU2706571A (en)
AU2724971A (en)
AU2726271A (en)
AU2740271A (en)
AU2755871A (en)
AU2837671A (en)
AU2854371A (en)
AU2875571A (en)
AU2963771A (en)
AU2885171A (en)
AU3038671A (en)
AU3025871A (en)
AU2907471A (en)
AU2927871A (en)